Immucor, Inc. (Immucor) develops, manufactures and sells a line of reagents and automated systems that detect and identify certain properties of the cell and serum components of human blood for the purpose of blood transfusion. The Company has manufacturing facilities in the United States and Canada and sells its products through its direct sales network in the United States, Canada, Western Europe and Japan, as well as through third-party distributors in other markets. As of May 31, 2009, the Company had received orders for a total of 603 Echo instruments worldwide, including 121 orders in Europe including distributors, 470 orders in the United States and Canada, and 12 orders in Japan. On August 4, 2008, Immucor acquired BioArray Solutions Ltd.